Lisata Therapeutics Inc - Company Profile
Powered by 
All the data and insights you need on Lisata Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Lisata Therapeutics Inc Strategy Report
- Understand Lisata Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Lisata Therapeutics Inc (Lisata Therapeutics), formerly Caladrius Biosciences Inc, is a biopharmaceutical company. It discovers and develops cellular therapies for the treatment of cardiovascular indications and autoimmune diseases. It is investigating XOWNA for the treatment of coronary microvascular dysfunction; HONEDRA against critical limb ischemia and buerger’s disease. The company is also evaluating CLBS201 for the treatment of diabetic kidney disease (DKD); and CLBS14 to treat no-option refractory disabling angina. Lisata Therapeutics utilizes its proprietary CD34+ cell therapy technology to develop therapies for ischemia diseases. It serves biotechnology, pharmaceutical and medical product companies, and academic research institutions. Lisata Therapeutics is headquartered in Basking Ridge, New Jersey, the US.
Headquarters
United States of America
Address
110 Allen Road, Second Floor, Basking Ridge, New Jersey, 07920
Website
www.lisata.com
Telephone
1 908 2292590
No of Employees
25
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
LSTA (NASD)
EPS
XYZ
Net Income (2022)
XYZ
61.6%
(2022 vs 2021)
Market Cap*
$23.5M
Net Profit Margin (0 vs)
XYZ
0.0%
(2022 vs 2021)
* As of and is in US$
Lisata Therapeutics Inc premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pipeline | XOWNA |
| XOWNA: | HONEDRA |
| Coronary Microvascular Dysfunction | |
| XYZ | |
| XYZ | |
| XYZ |
Competitor Comparison
| Key Parameters | Lisata Therapeutics Inc | Acorda Therapeutics Inc | Capricor Therapeutics Inc | Provention Bio Inc | Cyclacel Pharmaceuticals Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Basking Ridge | Pearl River | Beverly Hills | Red Bank | Berkeley Heights |
| State/Province | New Jersey | New York | California | New Jersey | New Jersey |
| No. of Employees | 25 | 102 | 101 | 174 | 12 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Gregory B. Brown | Chairman | Executive Board | 2017 | 69 |
| David J. Mazzo Phd | Chief Executive Officer; Director; President | Executive Board | 2017 | 66 |
| Gregory S. Berkin | Chief Information Officer | Senior Management | - | - |
| Kristen K. Buck | Chief Medical Officer; Executive Vice President - Research and Development | Senior Management | - | 49 |
| Tariq Imam | Vice President - Business Development , Operations and Corporate Counsel | Senior Management | 2016 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer